Drug intelligence / Profile preview

Oxothiazolidinecarboxylic acid

Development stage
Phase 2
Lead developer
Spec-Chem Industry
Modality
Small Molecules
Administration
Oral, Intravenous, Topical
01

Overview

Oxothiazolidinecarboxylic acid (also known as procysteine or OTC) is a small molecule prodrug of cysteine and an antioxidant. It is metabolized intracellularly to cysteine, thereby stimulating glutathione synthesis. This mechanism supports cellular antioxidant defenses by increasing the availability of glutathione, a key endogenous antioxidant. Oxothiazolidinecarboxylic acid has been investigated for its potential therapeutic effects in conditions associated with oxidative stress and glutathione deficiency. Clinical studies have explored its use in HIV infection and vascular calcification due to its ability to replenish intracellular cysteine and maintain glutathione levels[2][3][6]. It has also been used as an ingredient in personal care products due to its safety profile[1][7].

Brand names
Procysteine
Other names
2-oxothiazolidine-4-carboxylic acid(4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid
02

Targets

OPLAH (5-oxoprolinase (ATP-hydrolysing))SMCT1 (Sodium-coupled monocarboxylate transporter 1)HCAR2 (Hydroxycarboxylic acid receptor 2)

Beyond the preview

Go deeper on Oxothiazolidinecarboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxothiazolidinecarboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call